NCT00189774 Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients Status COMPLETED Phase PHASE2/PHASE3
NCT00179400 The Role of Acute Combined PPAR Alpha and Gamma Stimulation on Insulin Action in Humans Status COMPLETED Phase PHASE4
NCT00153179 Free Fatty Acids and Vascular Function in Subjects With Diabetes Status COMPLETED Phase PHASE1/PHASE2
NCT00147836 Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients Status COMPLETED Phase NA
NCT00141453 ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial Status COMPLETED Phase PHASE3
NCT00133718 A 2 Year Trial of Patients With Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic Control Status COMPLETED Phase PHASE4
NCT00131664 Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study) Status COMPLETED Phase PHASE3
NCT00130806 An Investigational Drug Co-Administered With Insulin in Patients With Type 2 Diabetes (0478-065) Status TERMINATED Phase PHASE3
NCT00129233 Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose Intolerance Status COMPLETED Phase PHASE4
NCT00128336 The Heat Study: 2 Year Lifestyle Intervention in Overweight Women to Encourage Weight Management Status COMPLETED Phase PHASE3
NCT00127192 A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044) Status COMPLETED Phase PHASE2
NCT00124397 Atorvastatin and Endothelial Function in Type 2 Diabetes Mellitus (ATTEND-Study) Status COMPLETED Phase PHASE4
NCT00123643 Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic Patients Status COMPLETED Phase PHASE4
NCT00123604 Vascular Effects of Carvedilol Versus Metoprolol in Hypertensive Patients With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00121966 South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT00110864 Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes Status COMPLETED Phase PHASE2